Project Grant R01CE003686
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$1.7M
Funding Federal Agency
National Center for Chronic Disease Prevention and Health Promotion
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.136
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This $2,930,360 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs aims to evaluate the real-world effectiveness of telehealth-delivered buprenorphine (tele-buprenorphine) treatment for opioid use disorder (OUD). The project will use innovative causal inference methods called emulated target trials to compare the effectiveness of tele-buprenorphine to in-person buprenorphine care, including for high-risk and...
The General Hospital Corporation, doing business as Massachusetts General Hospital, was awarded a $2,567,825 project grant from the Department of Health and Human Services Health Resources and Services Administration Bureau of Health Professionals to implement the INTEGRATED SUBSTANCE USE DISORDER (SUD) TRAINING PROGRAM. The five-year program, running from July 1, 2021 to June 30, 2026, aims to develop and expand the behavioral health workforce through the Mental and Behavioral Health...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $425,636 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), over a 5-year period from September 30, 2024 to July 31, 2029. The primary purpose of this award is to support a mentorship program led by an experienced HIV and substance use researcher at MGH. The mentoring will focus on training pre- and...
The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), received a $563,724 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support (CFDA 93.310) program. The project aims to provide a comprehensive, national picture of the links between substance use, firearm injuries, and reinjury in a sample of 42 million Medicaid-enrolled youth aged 13-25 across the U.S. from 2016-2020. The project seeks to...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
This federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) provides $2,000,000 in funding to the Massachusetts Department of Public Health (MDPH) to increase behavioral health screening, access to mental health care, and improve the quality of care for underserved individuals with co-occurring mental health and substance use...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $594,122 to Boulder Care, Inc. to develop and test telehealth workflows for delivering buprenorphine treatment for opioid use disorder (OUD) in vulnerable settings. The project aims to address barriers to OUD treatment access by providing smartphones and connectivity to individuals in high-risk situations, such as jails/prisons, emergency...
The federal Project Grant award, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, aims to address the opioid crisis in Massachusetts. The $238,107,340 award supports a comprehensive range of prevention, harm reduction, treatment, and recovery support services for opioid and stimulant use disorders, targeting high-risk populations including...
The Massachusetts Department of Public Health (MDPH) received a $1,993,123 federal Project Grant award from the U.S. Department of Justice, Bureau of Justice Assistance under the Harold Rogers Prescription Drug Monitoring Program (CFDA 16.754). The grant funding will support two principal enhancement objectives: Development of a "buprenorphine prompt" functionality within the Massachusetts Prescription Monitoring Program (MA PMP) to alert prescribers of gaps in buprenorphine...
The National Institutes of Health (NIH) awarded Boston Medical Center Corporation a $2,573,346 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The 3-year grant, which commenced on September 1, 2023, will fund a prospective cohort study comparing 100 opioid-exposed pregnancies to 50 non-exposed controls. The study aims to: Compare serial microRNA (miRNA) signatures in opioid-exposed and control pregnancies using maternal plasma and placental tissue samples. The...